All Tags » IPO's » (CELG) ( RSS)

Browse Site by Tags

Showing related tags and posts accross the entire site.

  • Issue: 3/19/2008

    The Playbook 100 CELG @ $57.68 (Celgene) develops therapies to treat cancer and immune-inflammatory related diseases. Revenues have increased between 43% and 76% during each of the last four quarters. Earnings have increased between 72% and 136% during the same time frame and are expected to grow 43...
    Posted to The Stock Playbook (Weblog) by Dave Dispennette on 03-19-2008
Page 1 of 1 (1 items)
© 2003-2008 InvestorsInsight Publishing, Inc.
Investor Blogs
John Mauldin's Thoughts From The Frontline
John Mauldin's Outside The Box
Forecasts & Trends by Gary D. Halbert
Daily Pfennig by Chuck Butler
Musing on the Markets by Vinny Catalano, CFA
Useful Links
Advertise
Privacy Policy
Legal Statement
Who Is Online
Help